Stocks Surge To Start Week… And Structure Therapeutics CEO On Weight Loss Space 3/24/25

Stocks Surge To Start Week… And Structure The...

Up next

Stocks Wrap Up A Volatile Week… And Playing Defense Amid The Market Swings 4/2/26

Stocks paring early losses to round out a volatile shortened week. How President Trump’s Iran War address impacted the markets, and the latest oil surge pushing WTI Crude prices back to triple digits. Plus Tesla’s disappointing deliveries, Bitcoin’s latest leg lower, and how one ...  Show more

Markets Rally Ahead of Trump’s Iran Address… And Fading The Bounce 4/1/26

Stocks bounce as traders brace for President Trump’s address on Iran, but the uncertainty isn’t going away. Why one top macro investor isn’t believing the bounce and says it’s time for a “cash buffer.” Plus, the spring housing bummer as mortgage rates rise, Nike hits 10+ year low ...  Show more

Recommended Episodes

Dollar Drops, Gold Rises as Trump Ousts Fed's Cook
Bloomberg Daybreak: Asia Edition

The dollar dropped and gold gained after President Donald Trump removed Federal Reserve Governor Lisa Cook, raising concerns about the independence of the central bank. A gauge of the dollar retreated 0.3% as Cook will be removed from the position effective immediately, according ...  Show more

COVID-19 Vaccine Optimism, Business Leaders' Message To President Trump, And Retail Stocks' Big November Rally
Squawk on the Street

Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no ser ...

  Show more

Stocks Surge, Moderna Skyrockets, Goldman’s Blowout Quarter, Needham Ups Apple
Squawk on the Street

Carl Quintanilla, Jim Cramer and David Faber discuss the surge in stocks. Markets getting a boost from blowout results from Goldman Sachs and Moderna’s vaccine news. Goldman Sachs crushing earnings estimates its biggest outperformance in nearly a decade. Revenue was more than ...

  Show more

Fresnillo Gains, AstraZeneca Rebounds, Nexans Drops
Stock Movers

On this episode of Stock Movers: - Fresnillo gained on gold and silver's record highs as HSBC analysts raised its recommendation to hold from reduce. _ AstraZeneca rebound following a deal with the Trump administration to lower drug prices in the US in exchange for tariff relief. ...  Show more